Assessment of effects of combination of SGLT2 inhibitors and renin–angiotensin–aldosterone system blockers on the renal functions of patients of diabetic kidney disease (SGRASS-DKD study)

Introduction: With the advent of the novel class of drug, SGLT-2-I, there are many speculations about the combined use of this class of drug with renin–angiotensin–aldosterone system inhibitors (RAAS-I) and their effects on DKD. In spite of the fact, that there is a huge prevalence of DM in India,...

Mô tả đầy đủ

Chi tiết về thư mục

Những tác giả chính:	Susovan Halder, Arnab Bhattacharyya, Shatavisa Mukherjee, Bhaswar Konar, Antareep Halder
Định dạng:	Artigo
Ngôn ngữ:	Inglês
Được phát hành:	Wolters Kluwer Medknow Publications 2024-01-01
Loạt:	Journal of Diabetology
Những chủ đề:	2-acr; dkd-i-i; raas; sglt
Truy cập trực tuyến:	https://journals.lww.com/jodb/fulltext/2024/15010/assessment_of_effects_of_combination_of_sglt2.9.aspx
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!